Expanding Knowledge About Advantages of Low-Sodium Oxybates: Richard Bogan, MD, FCCP, FAASM
June 9th 2022The associate clinical professor at the University of South Carolina School of Medicine discussed how JZP-258’s clinical profile has expanded since its original approval for narcolepsy, and whether it makes sense for all patients to consider. [WATCH TIME: 3 minutes]
Expanding the Use of Spinal Cord Atrophy in Multiple Sclerosis: Blake E. Dewey, PhD
June 4th 2022The postdoctoral researcher at the Johns Hopkins Multiple Sclerosis Center shared his perspective on the use of spinal cord atrophy in clinical practice to measure disease progression in MS and how it might become more accessible. [WATCH TIME: 4 minutes]
Women With MS Use Social Media to Augment Knowledge and Support: Riley Bove, MD
June 2nd 2022The associate professor of neurology at UCSF Weill Institute for Neurosciences discussed the findings of a social media listening study that suggested women with multiple sclerosis used social media platforms to discuss treatment during and around pregnancy. [WATCH TIME: 4 minutes]
Using a Holistic Approach to Improving Overall Patient Satisfaction in MS: Louise Palmer, MA
June 2nd 2022The health research assistant at the Shepherd Center discussed the need to improve access to interventions that improve the overall happiness of individuals with multiple sclerosis. [WATCH TIME: 4 minutes]
AUPN Leadership Minute Episode 22: Sharing Leadership: How to Select Vice-Chairs
June 2nd 2022Episode 23 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the VHA and Albany Medical College; and Robert Holloway, MD, MPH, of University of Rochester School of Medicine and Dentistry. [WATCH TIME: 6 minutes]
Shifting Focus From Relapses to Neurodegeneration in MS: Michael Levin, MD, FAAN, FANA
June 2nd 2022The professor of neurology at the University of Saskatchewan discussed the need to improve therapeutics aimed at improving neurodegeneration in patients with multiple sclerosis. [WATCH TIME: 3 minutes]
Tackling Neurodegeneration in MS Through A1 Antibodies: Michael Levin, MD, FAAN, FANA
June 1st 2022The professor of neurology at the University of Saskatchewan discussed his presentation at the 2022 CMSC Annual Meeting on using ribonucleoprotein A1 antibodies to drive neurodegeneration in multiple sclerosis. [WATCH TIME: 4 minutes]
Solving the Biggest Questions About the Brain With Advanced Technology: Michael Sughrue, MD
May 31st 2022The founder and chief medical officer of Omniscient Neurotechnology commented on the areas of need with understanding the brain map and treating conditions with multiple pathway crossover. [WATCH TIME: 4 minutes]